Navigation Links
KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results
Date:8/11/2008

bsorption.

Repliva 21/7(R) currently holds a 7.6% new prescription share, up from 5.9% in the first quarter of the previous fiscal year, representing the highest new prescription share of all branded oral iron products in the United States.

Advanced Prescription Nutritionals

Net revenues for all of the products that comprise Ther-Rx's advanced prescription nutritional line were $27.5 million, comparable with the first quarter of fiscal 2008.

-- Ther-Rx maintained its market leading position as the most prescribed prenatal vitamin franchise in the United States with a 43.9% share of the branded prescription prenatal market.

-- Net sales from our advanced prescription nutritional product line were comparable with the prior year quarter. The year-over-year comparison of sales of this product line was negatively impacted by $3.0 million in lower volume due to larger-than-normal customer purchases made in the first quarter last year due to anticipated price increases.

-- The PrimaCare(R) line of products maintained a 47.1% share of the Omega-3 (Essential Fatty Acid) segment of the branded prescription nutritional marketplace.

Gestiva(TM)

In January 2008, KV acquired an important asset that we anticipate will be added to the Ther-Rx women's healthcare line of products. The Company entered into a definitive product purchase agreement in fiscal 2008 that gives KV full U.S. and worldwide rights to Gestiva(TM) (17a-hydroxyprogestorone caproate) upon FDA approval of the pending New Drug Application for this product. The pending NDA seeks approval of Gestiva(TM), which has been granted an Orphan Drug Designation by the FDA, for use in the prevention of preterm birth for women with a history of at least one spontaneous preterm delivery (i.e., less than 37 weeks) who are pregnant with a single fetus. A PDUFA date by which FDA is expected to make a decision on the Gestiva(TM) NDA is October 24, 2008. We believe that Gestiva(T
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...21 The University of T...nning of a collaborative effort to eradicate breas...ast Cancer Awareness and Research of the Americas ...of the United States, and Vivian Fernandez de Torr... M. D. Anderson in the initiative are the U.S. Dep...
(Date:11/21/2008)..., Nov. 21 U.S. News &am...lity Assurance (NCQA) ranked BlueChoice(R) HealthP...s Best Health Plans(TM), published in U.S. News &a... respected annual ranking ranks the nation,s best ...isfaction and NCQA accreditation scores. NCQA and ...
(Date:11/21/2008)...popular drugs do not cause genetic damage that can...althDay News) -- Two popular medications for treat...) do not cause genetic damage linked to an increas..., The study, done by researchers at Duke Univers...Health, counters a previous one that reported biom...
(Date:11/21/2008)... 21 /PRNewswire/ -- For the second year in a ro...ann Healthcare Worldwide,s agency network won more...the 22nd annual international RX Club Show. , ...ces won a total of 59 RX Club Awards of Excellence...ann Healthcare Worldwide agencies include Caudex M...
Breaking Medicine News(10 mins):Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4
...udy involving more than 413,000 persons from 10 co... of vigorous activity or two hours// of moderate a... occurring by 22 to 35 per cent. Christine Frieden...esearch on Cancer in Lyon, France, and the Alberta...
...if they are overweight tend to reach out to low fa...hted// in a recent study (Journal of Marketing Res...the survey it was observed that participants were ...up with low fat snacks. They tended to eat less ...
... symptoms of hysteria are often ticked off, by ph...ir apparent ailment.// However, researchers from S... is merely a state of extreme emotions or emotiona...detect evidence to prove evidence of dysfunction i...
...ghly $20 billion to treat the nearly 2 million Ame...re inpatient care//, according to a new report by ...edicare and Medicaid are billed for almost half of...rcent of hospital stays of injured patients are un...
Other Medicine News:
(Date:11/20/2008)...PRNewswire-USNewswire/ -- The following is being r..., , WHAT: World AIDS Day Audio Media Conf... 25, 2008 , 11:00 a.m. EST , Call-in number:...tps://cc.readytalk.com/r/1xe41i2yre8rs , , ...er of people newly put on treatment worldwide, adv...
(Date:11/20/2008)...and, November 20 Arpida ...ve Drugs Advisory Committee of the,U.S. Food and ...t the,approval of intravenous iclaprim, an antibi...f patients with complicated skin and skin structur...methicillin-resistant Staphylococcus,aureus (MRSA...
(Date:11/20/2008).... 20 Radius Health ("Radius") anno...illion to its second institutional financing round...llion and the total amount raised since the compan...itutional investors participated in the financing,...g MPM Capital, The Wellcome Trust, HealthCare Vent...
(Date:11/19/2008)...9 Posit Science Corporation,resea...ty for Neuroscience,Annual Conference in Washingt...ng may benefit Baby Boomers. The computerized bra...es adaptive exercises that target auditory and,la...ve generalized,improvements in cognition by impro...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Faulty brain connections may be responsible for social impairments in autism 21702 1Faulty brain connections may be responsible for social impairments in autism 21702 2Centromeres cross over a lot 3624 1Study pinpoints strategies that protect older adults physical health 21700 1Study pinpoints strategies that protect older adults physical health 21700 2Carnegie Mellon researchers improve assessments of aortic aneurysms 21698 1Carnegie Mellon researchers improve assessments of aortic aneurysms 21698 2
...ticipates second quarter BLA filing for C1-inhibit...PRNewswire-FirstCall/ -- Lev,Pharmaceuticals, Inc....ivotal U.S. Phase III trial of C1-esterase inhibit...angioedema (HAE). In the,acute study, which is par...Hereditary Angioedema Nanofiltration Generation,ev...
...Calif.--(BUSINESS WIRE)--Mar 15, 2007 - A small cl...has failed to find any,conclusive benefit for pati...ng to researchers at the Stanford University,Schoo...sibility that some,medications, including the one ...for certain patients. , More than 1.2 million peop...
Other Medicine Technology:Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 2Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 5Stanford Study Finds No Conclusive Benefit From Treating,Kleptomania With Medication 2
...erior Chamber Lenses: The Bausch & Lomb PMMA Poste... used for primary implantation for the visual corr...lder where a cataractous lens has been removed by ... intended to be placed in the ciliary sulcus or ca...
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Multipiece PMMA IOL - Sulcus Fixation.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Medicine Products: